Literature DB >> 15953588

Angiogenesis inhibitors: from laboratory to clinical application.

Toshikazu Nakamura1, Kunio Matsumoto.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15953588     DOI: 10.1016/j.bbrc.2005.06.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  8 in total

Review 1.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.

Authors:  Jacob E Koskimaki; Emmanouil D Karagiannis; Elena V Rosca; Farhad Vesuna; Paul T Winnard; Venu Raman; Zaver M Bhujwalla; Aleksander S Popel
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  Acurhagin-C, an ECD disintegrin, inhibits integrin alphavbeta3-mediated human endothelial cell functions by inducing apoptosis via caspase-3 activation.

Authors:  Wen-Jeng Wang
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.

Authors:  Elena V Rosca; Jacob E Koskimaki; Niranjan B Pandey; Antonio C Wolff; Aleksander S Popel
Journal:  Cancer Biol Ther       Date:  2011-11-01       Impact factor: 4.742

Review 5.  Anti-angiogenic peptides for cancer therapeutics.

Authors:  Elena V Rosca; Jacob E Koskimaki; Corban G Rivera; Niranjan B Pandey; Amir P Tamiz; Aleksander S Popel
Journal:  Curr Pharm Biotechnol       Date:  2011-08       Impact factor: 2.837

6.  Identification of peptides derived from the C-terminal domain of fibulin-7 active for endothelial cell adhesion and tube formation disruption.

Authors:  Susana de Vega; Kentaro Hozumi; Nobuharu Suzuki; Risa Nonaka; Eimi Seo; Anna Takeda; Tomoko Ikeuchi; Motoyoshi Nomizu; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Biopolymers       Date:  2016-03       Impact factor: 2.505

7.  Using a Classifier Fusion Strategy to Identify Anti-angiogenic Peptides.

Authors:  Lina Zhang; Runtao Yang; Chengjin Zhang
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

8.  Disruption of the thrombospondin-2 gene alters the lamellar morphology but does not permit vascularization of the adult mouse lumbar disc.

Authors:  Helen E Gruber; Paul Bornstein; E Helene Sage; Jane A Ingram; Natalia Zinchenko; H James Norton; Edward N Hanley
Journal:  Arthritis Res Ther       Date:  2008-08-21       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.